[1]
K. Karthickeyan, A. Saara, K. Gopal, S. Karthick, and A. Ashi, “A REVIEW ON GLIMEPIRIDE VS TENELIGLIPTIN AS A SECOND-LINE DRUG FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”, JESM, vol. 2, no. 3, pp. 73-79, Sep. 2023.